Replying to "Parmacy Company GlaxoSmithKline Pays 23andMe $300 Million for 4+ Years of Exclusive Access to Over 5 Million Customers' DNA to Develop New Medications"
Discard
Compose Show Preview

Looks like your connection to PhatWallet was lost, please wait while we try to reconnect.